To find out whether AP-2 factors do contribute functionally to ERBB2 overexpression in vivo, we measured ERBB2 mRNA levels in breast cancer cells in which the expressions of AP-2α and AP-2γ were downregulated by siRNAs. The gene discussed is ERBB2; the disease is breast cancer.